Canadian Generic Pharmaceutical Association (CGPA)
Registration:
19
of
33
(2020-06-17
to
2020-06-17)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Developing a regulatory pathway for biosimilars. Addressing use of brand coupon cards. Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement and the USMCA. Implementation of commitments made by British Columbia pursuant to its involvement with the pan-Canadian Pharmaceutical Alliance. Payment of distribution fees by the government. Promoting greater utilization of generic prescription medicines. British Columbia's position on the National Pharmacare initiative. Maintenance of bilateral meetings. Provincial government policy on opioid prescribing and dispensing. Accelerating listing of generic drugs through regulatory reform.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|